If Quest Diagnostic’s logo isn’t on the COVID-19 test packet in the drive-thru at CVS, it could be spotted outside a lab on Greenville’s Roper Mountain Road or at Seneca’s Quick Draws blood test collection site.
Continuing to make inroads into the Upstate, the company has acquired almost all assets of Labtech Diagnostics, an Anderson-based diagnostic laboratory serving physicians and patients in the Carolinas, Georgia and Florida.
Anderson’s Labtech location joined the national network of Quest Diagnostics laboratories, making it the first full-service laboratory owned by Quest in South Carolina.
“Labtech Diagnostics is a vibrant business and brand that patients and providers have come to rely on as a crucial provider, particularly for COVID-19 testing during the pandemic,” Alan Myers, vice president and general manager of Quest Diagnostics’ Southeast region operations. “They share our commitment to empowering better patient care and outcomes, and we look forward to working together to bring our diagnostic innovations to more patients in the Southeast. We are especially thrilled to establish our first lab in South Carolina, which will continue to be an important base for serving providers and patients across the state.”
The acquisition enables more physicians in the state to access diagnostic services directly from Quest through its Cleveland HeartLab Cardiometabolic Center of Excellence and other laboratories in Atlanta, Tampa, Fla., and Greensboro, N.C.
“Quest and Labtech share a commitment to patient care, quality and innovation,” Joseph Labash, CEO of Labtech Diagnostics, said in a statement. “It was important that Labtech collaborate with a provider committed to building on our reputation for outstanding service and patient-centric care. Quest’s previous work and vision for the future made them the clear choice to partner with through acquisition.”
The statement said Labtech Diagnostics selected Quest based on several factors, such as Quest Diagnostics' status and rapport as a leader in the diagnostic field and the company’s commitment to close health care gaps for underserved communities.
"Our acquisition of Labtech Diagnostics delivers on our accelerate growth strategy in the Southeast and vision of a healthier world," Steve Rusckowski, chairman, CEO and president of Quest Diagnostics, said in a statement. "Establishing a laboratory in South Carolina will enable us to provide diagnostic insights empowering affordable care to more patients and providers while building on our growth aims in the region."
To date, Quest has performed and reported more than 63.2 million COVID-19 molecular diagnostic and antibody serology tests through retail providers and the QuestDirect consumer-initiated testing platform, the release said.
Quest Diagnostics locations in Greenville, Rock Hill, Columbia, Irmo, Orangeburg, Lancaster, Aiken, Charleston, Summerville, Hilton Head and Bluffton offer limited diagnostic services.